gilteritinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

Children's Oncology Group (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadacute myeloid leukemia

I am/have/hadblood count

I am/have/hadblast cells

I am/have/hadheart problems

I am/have/hadcongenital heart block

I am/have/haddown syndrome

I am/have/hadallogeneic hematopoietic stem cell transplant

I am/have/hadblast count

I am/have/hadwilliams syndrome

I am/have/hadblood cell count

I am/have/hadwhite blood cell count

I am/have/hadleukemia

I am/have/hadflt3 gene

I am/have/hadresidual leukemic cells

I am/have/hadmyeloid leukemia

I am/have/hadfibrosis

I am/have/hadneuropsychological testing

I am/have/hadvision test

I am/have/hadleukemic cells

I am/have/hadcell transplantation

added new label for I am/have/had

more

I am looking for

I am looking forgilteritinib

I am looking foranthracyclines

I am looking formethotrexate

I am looking forgemtuzumab

I am looking forcytarabine

I am looking forcytarabine/daunorubicin

I am looking foretoposide

I am looking forgemtuzumab ozogamicin

I am looking formitoxantrone

I am looking forchemotherapy drug

I am looking fordaunorubicin

I am looking foranthracycline

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
all
Hematology
Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Giving CPX-351 and/or gilteritinib with standard chemotherapy may work better in treating patients with acute myeloid leukemia compared to standard chemotherapy alone.

acute myeloid leukemia

heart problems

allogeneic hematopoietic stem cell transplant

williams syndrome

gilteritinib

0 views
2 annotations
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.